Our innovation approach: Beyond discovery
We don’t invent new drugs — we make proven medicines work better in the real world. Many injectable treatments are clinically effective but inefficient to prepare, uncomfortable for patients, or burdensome for healthcare systems. The molecule works. The delivery often does not. Tatva Pharma redesigns how these medicines are formulated and administered.
Redefining medicine delivery
Tatva Pharma isn't about discovering new molecules; it's about perfecting the delivery of established ones. We create long-acting depots, ready-to-use injectables, and smoother release profiles that reduce side effects, simplify preparation, and improve adherence. By combining advanced formulation science with predictive data tools, we reduce development risk and focus solely on solutions that are clinically meaningful and regulatorily viable. If the medicine works, the way it is delivered should work just as well.
Usability, predictability, impact
Unlike traditional pharmaceutical companies that chase new molecules or compete on price, Tatva Pharma takes proven medicines and redesigns how they are delivered. We make them simpler, longer-acting, safer to administer, and smarter to scale. While others focus on discovery, we prioritise usability, predictability, and real-world impact for the benefit of healthcare across the UK and beyond, ensuring differentiation without discovery risk.
Who benefits, and what we fix
Our innovation directly impacts key stakeholders:
Patients: Experience fewer doses, smoother drug levels, and reduced side effects, transforming treatments that were once hard to live with into manageable therapies.
Clinicians & Hospitals: Benefit from ready-to-use, faster injectables with fewer preparation steps, alleviating time pressure and reducing medication-error risk.
Healthcare Systems: Achieve better adherence and operational efficiency, tackling high costs often driven by inefficient drug delivery methods.
Pharma Partners: Gain de-risked, patent-smart injectable assets, offering significant differentiation without the uncertainties of new drug discovery.
"Transforming the patient experience: A real-world example"
Imagine a medicine that currently requires a two-hour hospital infusion. It works — but it ties up nurses, infusion chairs, and patients for half a day. Our process begins by asking a different question: Can this same molecule be redesigned into a short, ready-to-use injection without compromising efficacy? We use predictive modelling to assess feasibility before entering the lab — analysing excipient compatibility, release kinetics, and regulatory pathways. Only once the science and regulatory logic align do we move into formulation development. The goal isn’t to change the medicine. It’s to change the experience of receiving it. That mindset — improving delivery, reducing friction, and designing for real-world healthcare — is exactly what Tatva Pharma is about.
A testament to thoughtful healthcare innovation